Giacobbe, Daniele Roberto
Dettori, Silvia
Di Pilato, Vincenzo
Asperges, Erika
Ball, Lorenzo
Berti, Enora
Blennow, Ola
Bruzzone, Bianca
Calvet, Laure
Capra Marzani, Federico
Casabella, Antonio
Choudaly, Sofia
Dartevel, Anais
De Pascale, Gennaro
Di Meco, Gabriele
Fallon, Melissa
Galerneau, Louis-Marie
Gallego, Miguel
Giacomini, Mauro
González Sáez, Adolfo
Hänsel, Luise
Icardi, Giancarlo
Koehler, Philipp
Lagrou, Katrien
Lahmer, Tobias
Lewis White, P.
Magnasco, Laura
Marchese, Anna
Marelli, Cristina
Marín-Arriaza, Mercedes
Martin-Loeches, Ignacio
Mekontso-Dessap, Armand
Mikulska, Malgorzata
Mularoni, Alessandra
Nordlander, Anna
Poissy, Julien
Russelli, Giovanna
Signori, Alessio
Tascini, Carlo
Vaconsin, Louis-Maxime
Vargas, Joel
Vena, Antonio
Wauters, Joost
Pelosi, Paolo
Timsit, Jean-Francois
Bassetti, Matteo
,
Cerchiaro, Matteo
Zaccarelli, Mario
Robba, Chiara
Battaglini, Denise
Brunetti, Iole
Del Puente, Filippo
Mora, Sara
de la Villa, Sofía
Valerio, Maricela
Muñoz, Patricia
Lombardi, Gianmarco
Cesarano, Melania
Gennenzi, Veronica
Meersseman, Philippe
Hermans, Greet
Wilmer, Alexander
Razazi, Keyvan
Carteaux, Guillaume
de Prost, Nicolas
Cornely, Oliver A.
Seidel, Danila
Alastruey-Izquierdo, Ana
Garcia Borrega, Jorge
Bonnal, Christine
de Montmollin, Etienne
Dessajan, Julien
Ceresini, Mariaelena
Mojoli, Francesco
Vola, Ambra
Garnaud, Cécile
Díaz, Emili
Gasch, Oriol
Prina, Elena
Rasch, Sebastian
Dibos, Miriam
Haschka, Stefanie
,
Article History
Received: 26 April 2023
Accepted: 10 August 2023
First Online: 24 August 2023
Declarations
:
: The study was approved by ethics committee of the coordinating center (Liguria Region Ethics Committee, N. Registro CER Liguria 305/2021). Informed consent was waived due to the retrospective nature of the study. The other participating centers followed the local ethical requirements.
: Outside the submitted work, DRG reports investigator-initiated grants from Pfizer, Shionogi, and Gilead Italia, and speaker and/or advisor fees from Pfizer and Tillotts Pharma. Outside the submitted work, MB reports research grants and/or personal fees for advisor/consultant and/or speaker/chairman from BioMérieux, Cidara, Gilead, Menarini, MSD, Pfizer, and Shionogi. Outside the submitted work, VDP reports research grant from Seegene Inc. Outside the submitted work, PLW performed diagnostic evaluations and received meeting sponsorship from Bruker; speakers fees, expert advice fees and meeting sponsorship from Gilead; expert advice fees from F2G and speaker fees from Pfizer; speakers fees and performed diagnostic evaluations for Associates of Cape Cod and IMMY. JW received meeting speakers and travel fees and investigator-initiated grants from MSD, Gilead and Pfizer, outside the scope of this manuscript. Outside the submitted work, PK reports grants or contracts from German Federal Ministry of Research and Education (BMBF) B-FAST (Bundesweites Forschungsnetz Angewandte Surveillance und Testung) and NAPKON (Nationales Pandemie Kohorten Netz, German National Pandemic Cohort Network) of the Network University Medicine (NUM) and the State of North Rhine-Westphalia; Consulting fees Ambu GmbH, Gilead Sciences, Mundipharma Resarch Limited, Noxxon N.V. and Pfizer Pharma; Honoraria for lectures from Akademie für Infektionsmedizin e.V., Ambu GmbH, Astellas Pharma, BioRad Laboratories Inc., Datamed GmbH, European Confederation of Medical Mycology, Gilead Sciences, GPR Academy Ruesselsheim, HELIOS Kliniken GmbH, Lahn-Dill-Kliniken GmbH, medupdate GmbH, MedMedia GmbH, MSD Sharp & Dohme GmbH, Pfizer Pharma GmbH, Scilink Comunicación Científica SC and University Hospital and LMU Munich; Participation on an Advisory Board from Ambu GmbH, Gilead Sciences, Mundipharma Resarch Limited and Pfizer Pharma; A pending patent currently reviewed at the German Patent and Trade Mark Office (DE 10 2021 113 007.7); Other non-financial interests from Elsevier, Wiley and Taylor & Francis online. The other authors report no conflicts of interests related to this study.